A low-sodium solution for airway care: Results of a multicenter trial

Respiratory Care

Volumn 55, Issue 12, 2010, Pages 1680-1685

  Christensen, Robert D ^a   Henry, Erick ^a   Baer, Vickie L ^a   Hoang, Nhanp ^a   Snow, Gregory L ^b   Rigby, Gorgi ^a   Burnett, Jill ^a   Wiedmeier, Susan E ^a   Faix, Roger G ^a   Eggert, Larry D ^a  

^a INTERMOUNTAIN HEALTHCARE   (United States)

^b LDS HOSPITAL   (United States)

Author keywords

Airway care; Chronic lung disease; Endotracheal tube; Nosocomial infection; Saline; Sepsis; Ventilator associated pneumonia

Indexed keywords

SODIUM;

ARTICLE; BIRTH WEIGHT; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTRACHEAL INTUBATION; FEMALE; GESTATIONAL AGE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LENGTH OF STAY; MALE; MULTICENTER STUDY; NEWBORN; NEWBORN INTENSIVE CARE; OXYGEN SUPPLY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY CARE; VENTILATOR ASSOCIATED PNEUMONIA;

BIRTH WEIGHT; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE, NEONATAL; INTUBATION, INTRATRACHEAL; MALE; PNEUMONIA, VENTILATOR-ASSOCIATED; RESPIRATION, ARTIFICIAL; RISK FACTORS; SODIUM CHLORIDE;

EID: 78650507885     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Pedersen CM, Rosendahl-Nielsen M, Hjermind J, Egerod I. Endotracheal suctioning of the adult intubated patient-what is the evidence? Intensive Crit Care Nurs 2009;25(1):21-30.
2. Trawoger R, Kolobow T, Cereda M, Giacomini M, Usuki J, Horiba K, Ferrans VJ. Clearance of mucus from endotracheal tubes during intratracheal pulmonary ventilation. Anesthesiology 1997;86(6):1367-1374.
3. Kinloch D. Instillation of normal saline during endotracheal suctioning: effects on mixed venous oxygen saturation. Am J Crit Care 1999;8(4):231-240.
4. Lindgren S, Almgren B, Hogman M, Lethvall S, Houltz E, Lundin S, Stenqvist O. Effectiveness and side effects of closed and open suctioning: an experimental evaluation. Intensive Care Med 2004;30(8): 1630-1637.
5. Cunha-Goncalves D, Perez-de-Sa V, Ingimarsson J, Werner O, Larsson A. Inflation lung mechanics deteriorates markedly after saline instillation and open endotracheal suctioning in mechanically ventilated healthy piglets. Pediatr Pulmonol 2007;42(1):10-14.
6. Doss M, White MR, Tecle T, Hartshorn KL. Human defensins and LL-37 in mucosal immunity. J Leukocyte Biol 2010;87(1):79-92.
7. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson JM. Human-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 1997;88(4):553-560.
8. Smith JJ, Travis SM, Greenberg EP, Welsh MJ. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 1996;85(2):229-236.
9. Zabner J, Sieler MP, Launspach JL, Karp PH, Kearney WR, Look DC, et al. The osmolyte xylitol reduces the salt concentration of airway surface liquid and may enhance bacterial killing. Proc Natl Acad Sci USA 2000;10;97(21):11614-11619.
10. Zabner J, Smith JJ, Karp PH, Widdicombe JH, Welsh MJ. Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro. Mol Cell 1998;2(3):397-403.
11. Singh PK, Tack BF, McCray PB, Welsh M. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol 2000;279(5):L799-L805.
12. Travis SM, Conway BA, Zaabner J, Smith JJ, Anderson NN, Singh PK, et al. Activity of abundant antimicrobials of the human airway. Am J Respir Cell Mol Biol 1999;20(5):872-879.
13. Herr C, Shaykhiev R, Bals R. The role of cathelicidin and defensins in pulmonary inflammatory diseases. Expert Opin Biol Ther 2007; 7(9):1449-1461.
14. Ganz T. Antimicrobial polypeptides in host defense of the respiratory tract J Clin Invest 2002;109(6):693-697.
15. Bals R, Wilson JM. Cathelicidins: a family of multifunctional antimicrobial peptides. Cell Mol Life Sci 2003;60(4):711-720.
16. Wang Y, Walter G, Herting E, Agerberth B, Johansson J. Antibacterial activities of the cathelicidins prophenin (residues 62 to 79) and LL-37 in the presence of a lung surfactant preparation. Antimicob Agents Chemother 2004;48(6):2097-2100.
17. Putsep K, Carlsson G, Boman HG, Anderson M. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observational study. Lancet 2002;360(3940):1144-1149.
18. Cirioni O, Ghiselli R, Tomasinsig L, Orlando F, Silvestri C, Skerlavaj B, et al. Efficacy of LL-37 and granulocyte colony-stimulating factor in a neutropenic murine sepsis due to Pseudomonas aeruginosa. Shock 2008;30(4):443-448.
19. Woodhead DD, Lambert DK, Scoffield S, Snow G, Baer V, Christensen RD. Feasibility and preliminary safety study of a new physiologically based solution for upper airway care in the neonatal intensive care unit. Neo Int Care 2006;19:29-33.
20. Christensen RD, Rigby G, Schmutz N, Lambert DK, Wiedmeier SE, Burnett J, et al. ETCare: a randomized, controlled, masked trial comparing two solutions for upper airway care in the NICU. J Perinatol 2007;27(8):479-484.
21. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Therapeut 2002;27(4):299-309.
22. Carey AJ, Saiman L, Polin RA. Hospital-acquired infections in the NICU: epidemiology for the new millennium. Clin Perinatol 2008;35(1): 223-249.
23. Strunk T, Richmond P, Simmer K, Currie A, Levy O, Burgner D. Neonatal immune responses to coagulase-negative staphylococci. Curr Opin Infect Dis 2007;20(4):370-375.
24. Caruso P, Denari S, Ruiz SA, Demarzo SE, Dehinzelin D. Saline instillation before tracheal suctioning decreases the incidence of ventilator- associated pneumonia. Crit Care Med 2009;37(1):32-38.
25. Murray DM, Varnell SP, Blitstein JL. Design and analysis of grouprandomized trials: a review of recent methodological developments. Am J Public Health 2004;94(3):423-432.
26. Kollef MH, Afessa B, Anzueto A, Veremakis C, Kerr KM, Margolis BD, et al. on behalf of the NASCENT Investigation Group. Silvercoated endotracheal tubes and incidence of ventilator-associated pneumonia. JAMA 2008;300(7):805-813.
27. Fletcher AJW, Ruffell AJ, Young PJ. The LoTrachTM system: its role in the prevention of ventilator-associated pneumonia. Nurs Crit Care 2008;13(5):260-268.